BriaCell Reports Positive Breast Cancer Efficacy Data with Bria-IMT™ Immunotherapy Treatment at SITC Annual Meeting! The study was recently awarded U.S. Food and Drug Administration ("FDA") fast track designation. Read their press release from this morning for all the details: https://bit.ly/3UszlMc #Stocks #Nasdaq #StocksToWatch